Physician

Marc Abbate, MD

According to 2025 Medicare claims, Marc Abbate, MD (NPI: 1316911845) practices dermatology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Passaic, NJ. This provider's primary affiliated billing organization is SCHWEIGER DERMATOLOGY, PC (NPI: 1104229392; TIN: 470973312) and primary practice location at 07457-1603.

Abbate's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,024 traditional Medicare patients, billed 23,203 HCPCS/CPT codes, and received $1,435,355 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 2,413 prescription claims across 1,039 beneficiaries totaling $911,873 in drug costs, led by Humira Pen (Adalimumab). Open Payments data shows 334 records totaling $3,966. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $390,839 to $911,873. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$718K$1.4M2015 Medicare payment: $945,785 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $929,763 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $986,122 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $890,199 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $787,441 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $753,905 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $945,309 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,076,957 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,203,595 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,435,355 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,72417,123$945,785
20161,81617,567$929,763
20171,85719,362$986,122
20181,74917,736$890,199
20191,58515,580$787,441
20201,55614,278$753,905
20211,59516,184$945,309
20221,86020,219$1,076,957
20232,04023,461$1,203,595
20242,02423,203$1,435,355

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$514K$1.0M2015 Drug cost: $390,839 (USD; Tot_Drug_Cst)2016 Drug cost: $403,213 (USD; Tot_Drug_Cst)2017 Drug cost: $362,839 (USD; Tot_Drug_Cst)2018 Drug cost: $460,839 (USD; Tot_Drug_Cst)2019 Drug cost: $402,910 (USD; Tot_Drug_Cst)2020 Drug cost: $487,518 (USD; Tot_Drug_Cst)2021 Drug cost: $839,541 (USD; Tot_Drug_Cst)2022 Drug cost: $1,028,786 (USD; Tot_Drug_Cst)2023 Drug cost: $946,402 (USD; Tot_Drug_Cst)2024 Drug cost: $911,873 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20156051,414$390,839
20166941,516$403,213
20176731,524$362,839
20186561,479$460,839
20195951,378$402,910
20207472,150$487,518
20218022,143$839,541
20229132,386$1,028,786
20231,0082,467$946,402
20241,0392,413$911,873

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth1,4282,212$76
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,6522,765$69
11103Biopsy of related skin growth, each additional growth7051,123$44
17000Destruction of precancer skin growth, 1 growth1,3872,431$35
17003Destruction of precancer skin growth, 2-14 growths1,1188,104$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira PenAdalimumab13364$89,606
Dupixent PenDupilumab22602$81,326
OtezlaApremilast14420$61,822
VtamaTapinarof20780$25,585
Clobetasol PropionateClobetasol Propionate2607,392$9,891

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.334$3,966ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Marc Abbate, MD?

Tedicare shows public-source Medicare data for Marc Abbate, MD (NPI 1316911845), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Marc Abbate, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Marc Abbate, MD?

Marc Abbate, MD is linked to SCHWEIGER DERMATOLOGY, PC (billing NPI 1104229392) in the available physician profile data.

Does Marc Abbate, MD have Open Payments data?

Marc Abbate, MD has 334 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.